VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30006521 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30002266 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30075813 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30075814 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30018460 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30037172 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30037173 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30037174 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30037175 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
TVIS30037176 | HIV | ENSG00000090060.19 | protein_coding | PAPOLA | No | No | 10914 | A0A0C4DGK1 P51003 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | PAPOLA |
---|---|
DrugBank ID | DB03896 |
Drug Name | Triphosphoric acid |
Target ID | BE0004515 |
UniProt ID | P51003 |
Regulation Type | |
PubMed IDs | 17139284; 17016423; 10592235 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
Groups | Experimental |
Direct Classification | Non-metal phosphates |
SMILES | OP(O)(=O)OP(O)(=O)OP(O)(O)=O |
Pathways | Segawa Syndrome; Pterine Biosynthesis; Hyperphenylalaninemia Due to DHPR-Deficiency; Sepiapterin Reductase Deficiency; Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps); DOPA-Responsive Dystonia; Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency |
PharmGKB | |
ChEMBL | CHEMBL1230191 |